Premature ventricular contractions (PVCs). Other cardiac arrhythmias
Conditions
Interventions
Intervention 1: Intervention Group 1:In this group, bisoprolol will be initiated at a dose of 1.25 mg per day and will be titrated up to a maximum dose of 10 mg, depending on the patient’s condition,
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: Having symptomatic premature ventricular contractions confirmed by Holter monitoring Providing written informed consent to participate in the research project Having no contraindication to receiving beta-blockers, especially the two mentioned drugs
Exclusion criteria
Exclusion criteria: Lack of patient consent to continue participation in the study Contraindication to receiving beta-blockers, particularly the two study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency and symptoms of premature ventricular contractions (PVCs). Timepoint: At baseline and after six months of treatment with the mentioned drug. Method of measurement: The symptoms reported by the patient and the Holter rhythm monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasrin Nouraei
Ahvaz University of Medical Sciences
Outcome results
None listed